Cramer’s lightning round: AST SpaceMobile is an exciting thing, not a stock

Cramer’s lightning round: AST SpaceMobile is an exciting thing, not a stock


AST SpaceMobile Inc: “It’s an exciting thing, not a stock. I think a stock is a company that makes money and then returns some of that money to you and trades inexpensively, and that one doesn’t qualify.”

Cano Health Inc: “What the heck is going on with Cano Health? … The stock is just in freefall.”

Blue Bird Corp: “That school bus company is not to be touched, because they’re doing very poorly.”

MP Materials Corp: “It’s doing a great job, they’ve got a contract with GM. … GM’s a winner, and so is MP.”

Icon Plc: “I like it. It’s a very inexpensive stock.”

Cramer's lightning round: AST SpaceMobile is an exciting thing, not a stock

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More
Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More